We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stainless Staining Provides New Histology Tool for Researchers and Clinical Pathologists

By LabMedica International staff writers
Posted on 17 May 2015
Researchers have developed a potentially revolutionary system based on infrared spectroscopic imaging that enables stain-free, non-perturbing, multiple analyses of a single biological tissue sample. More...


Histology staining has evolved with non-specific stains, then immunohistochemical staining, and then digital imaging with computerized analysis. In these cases, the prepared biopsy samples are stained. In the new study, a team of engineers, pathologists, and surgeon, led by Prof. Rohit Bhargava of the Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, (Urbana and Champaign, IL, USA), used a new approach, based on Fourier transform infrared (FT-IR) spectroscopic imaging and computation, to develop stain- and label-free chemical imaging to provide the same information as molecular stains. This enables a rapid, digital, quantitative, and non-perturbing visualization of morphology and multiple molecular epitopes for various applications.

The spectra measure the chemical constitution of cells and tissues directly. With computational techniques, the researchers were able to relate spectral properties to known staining patterns of tissue. Using computation and the intrinsic molecular contrast of the tissue enabled molecular stains to be digitally produced without staining the tissue itself. Thus, staining can be visualized while leaving precious tissue pristine for downstream analyses and without the added material cost, time, and labor of direct tissue staining.

This approach also enables analysis of small samples (for example from a thin needle biopsy) or where it may not be possible to obtain multiple samples from the same biopsy for multiple stains. In cases where materials are limited or there may be a need to closely correlate multiple expressed molecules, the new method could be a solution, allowing the user to simply "dial-in" a required stain.

The study is timely as it builds on the emergence of chemical imaging and maturation of computation from the science and engineering side and the drive to greater molecular content information from the biomedical, clinical side. This approach has potential for immediate and long term impact in changing the field to a multiplexed molecular science in research and clinical practice, histology and pathology.

"We're relying on the chemistry to generate the ground truth and act as the "supervisor" for a supervised learning algorithm. A human has to verify that the stain was applied appropriately, but that's something that pathologists do very well", said lead author David Mayerich, assistant professor, University of Houston. Michael Walsh, assistant professor, University of Illinois at Chicago, added, "One of the bottlenecks in automated pathology is the extensive processing that must be applied to stained images to correct for staining artifacts and inconsistencies. The ability to apply stains uniformly across multiple samples could make these initial image processing steps significantly easier and more robust".

"FT-IR imaging allows histology digital imaging without destroying tissue properties caused by staining; therefore, the same slide can be used for other purposes (multiplex immunofluorescence and immunohistochemistry, or other methods). For research applications, it also allows higher throughput by rapidly marking up the tissues for regions of interest," said Dr. Andre Balla. "Infrared and optical imaging seemed to be distinct modes for getting important data in pathology. This study shows a close link between the two, allowing the user to choose the best method to address their needs," said Prof. Bhargava.

The study, by Mayerich D. et al, was published March 20, 2015, in the journal Technology.

Related Links:

University of Illinois at Urbana-Champaign 



New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Left is the original cell image and right is same cell image zoomed in and rendered in the special imaging software (Photo courtesy of FIU)

Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear

Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.